The EU Merger Regulation (EUMR) — Council Regulation (EC) No 139/2004 — is the legal framework under which the European Commission reviews mergers and acquisitions with an "EU dimension." It is the European counterpart to U.S. HSR/merger control, and for large cross-border deals touching Europe it is often the most consequential regulatory hurdle.
The "one-stop shop"
A defining feature of the EUMR is the "one-stop shop": deals above the EU turnover thresholds are reviewed once, at the EU level by the Commission's Directorate-General for Competition (DG COMP), rather than separately by each affected member state. This spares parties from multiple national filings within the EU. Deals below the EU thresholds may still require national merger filings in individual member states.
Jurisdiction: the "EU dimension"
Whether the EUMR applies turns on turnover (revenue) thresholds, not deal value. A concentration has an EU dimension if the combined worldwide and EU-wide turnover of the parties exceeds specified levels (with rules to ensure genuine EU nexus). Meeting the thresholds makes notification to the Commission mandatory and suspensory — the deal cannot close until cleared (closing early is "gun-jumping," subject to heavy fines).
The substantive test: SIEC
The Commission assesses whether a concentration would "significantly impede effective competition" (the SIEC test) in the internal market, in particular by creating or strengthening a dominant position. As in the U.S., the analysis defines the relevant market, measures concentration, and evaluates unilateral and coordinated effects, entry, and efficiencies.
The review timetable
EUMR review runs in two phases:
- Phase I — roughly 25 working days (extendable to 35 if remedies are offered). Most deals clear here, often unconditionally or with simple commitments.
- Phase II — opened if serious doubts remain: an in-depth investigation of about 90 working days (extendable), ending in unconditional clearance, clearance with remedies (divestitures or behavioral commitments), or — rarely — prohibition.
Power and reach
The Commission can block a deal outright (a power it exercises sparingly but notably) and impose structural remedies as a condition of clearance. Its jurisdiction is extraterritorial in effect: any deal — even between two non-EU companies — must clear the EUMR if the parties have sufficient European turnover, which is why global mergers routinely seek EU clearance alongside U.S. and other approvals. The Commission has also taken an expansive view in some areas (e.g., scrutinizing "killer acquisitions" and accepting certain below-threshold referrals), making EU clearance a key gating item in major cross-border M&A.
See also
- Antitrust and merger control — Government review of mergers to prevent harm to competition.
- Market definition — The threshold step in any antitrust merger analysis: identifying the relevant product and geographic market in which the parties compete, against which concentration is then measured.
- Herfindahl-Hirschman Index — A measure of market concentration calculated as the sum of squared market shares. Used by U.S. and EU antitrust authorities as the primary screening metric in merger reviews.
- Cross-border M&A — Transactions in which buyer and target are in different jurisdictions. Layers on currency, foreign-investment review, multi-jurisdiction tax planning, employment law and cultural-integration complexity.
- Hart-Scott-Rodino Act — The U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976, which requires premerger notification and an initial waiting period for transactions exceeding statutory size thresholds.